Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030
about
Urinary Stone Disease: Progress, Status, and Needs.The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease.Pathologic function and therapeutic potential of exosomes in cardiovascular disease.The association of metabolic syndrome and urolithiasisEvidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers.Impact of previous open renal surgery on the outcomes of subsequent percutaneous nephrolithotomy: a meta-analysisOnline Discussion on #KidneyStones: A Longitudinal Assessment of Activity, Users and Content.Association between Circulating Vitamin D Level and Urolithiasis: A Systematic Review and Meta-Analysis.Differential Roles of Peroxisome Proliferator-Activated Receptor-α and Receptor-γ on Renal Crystal Formation in Hyperoxaluric RodentsM1/M2-macrophage phenotypes regulate renal calcium oxalate crystal development.CUA guideline on the evaluation and medical management of the kidney stone patient - 2016 updateAssociations between interventions for urolithiasis and urinary tract cancer among patients in Taiwan: The effect of early intervention.Prevention of renal stone disease recurrence. A systematic review of contemporary pharmaceutical options.Geographic location is an important determinant of risk factors for stone disease.Kidney stones diseases and glycaemic statuses: focus on the latest clinical evidences.Bayesian comparative assessment of diagnostic accuracy of low-dose CT scan and ultrasonography in the diagnosis of urolithiasis after the application of the STONE score.Shock wave lithotripsy (SWL): outcomes from a national SWL database in New Zealand.Epidemiology and economics of nephrolithiasis.Does previous open renal surgery or percutaneous nephrolithotomy affect the outcomes and complications of percutaneous nephrolithotomy.Genome-Wide Gene Expression Profiling of Randall's Plaques in Calcium Oxalate Stone Formers.Compliance of the recurrent renal stone former with current best practice guidelines.Temporal Changes in Kidney Stone Composition and in Risk Factors Predisposing to Stone Formation.Low Bone Density and Bisphosphonate Use and the Risk of Kidney Stones.Effectiveness of Treatment Modalities on Kidney Stone Recurrence.Composition, microstructure and element study of urinary calculi.The effects of HAP and macrophage cells to the expression of inflammatory factors and apoptosis in HK-2 cells of vitro co-cultured system.Prevalence of metabolic syndrome in China: An up-dated cross-sectional study.Extracorporeal shock wave lithotripsy versus flexible ureterorenoscopy in the treatment of untreated renal calculi.Development of a personalized diagnostic model for kidney stone disease tailored to acute care by integrating large clinical, demographics and laboratory data: the diagnostic acute care algorithm - kidney stones (DACA-KS)Study on the prevalence and incidence of urolithiasis in Korea over the last 10 years: An analysis of National Health Insurance DataMedical therapy for nephrolithiasis: State of the artEffect of Tamsulosin on Passage of Symptomatic Ureteral Stones: A Randomized Clinical Trial
P2860
Q30373434-7E6690E9-EA58-4EE0-A87C-7A9131A7DB09Q33851630-024BF8E5-54DC-4CD1-9351-E77A415C9A9AQ34717025-2E82BB0E-CD68-4DA2-86CC-DAEDE3514A11Q35271466-38ED0730-3B19-481F-93E8-35C30499AF71Q35999340-550ED112-85A9-42C8-A854-014180439971Q36002617-21B6FF64-9BD5-4BD3-B128-3CB0CCAD2E08Q36106931-AC5046B1-ABE9-49AE-B048-6CF9199717BBQ36320757-411480EA-E0A8-4140-BC47-9593428075C5Q36679676-C7CE36C7-650F-43EE-86C1-2D845B7F792DQ37330448-D4148681-8896-4799-90CB-A269910A5A23Q37585262-3FD4F4AB-E7A2-4E91-A3B6-D1DCC2BC5EAEQ37606166-C4CAE4CE-4878-42E4-B6FC-79BB433FBBF6Q38424305-F39A12B2-FAB2-4B69-A0E5-6E11E0AA10A4Q38806113-FF1A803A-0942-4052-9A77-AEF67C9CE08AQ39030286-89907B45-570F-42AB-9384-9D064C463D43Q39155225-9CDD8757-1EBE-4439-8A79-5B08FACDDCF2Q39962685-75F719F3-9E9B-44E4-A056-5CE656D25802Q40059485-E5F2FC42-9171-43FC-8CBE-4AD724FD9A98Q40148715-26AD7AB7-9436-4B70-9FEB-102BF9029525Q47103946-AF68C7CF-7B16-4A6C-8C63-079BE8E15AFFQ47184196-07418109-936A-4F2B-BB8C-59FB09E465CBQ47580054-10637EB3-4286-4328-973C-58C5E3385127Q47743274-B1048D0B-3BCA-4BC3-8993-D8CE6CF63178Q47919786-2CD52F78-028B-4752-8BA7-C4895B74B39EQ47965385-E5B153D0-4FA5-4952-8D36-0ABDDF4D7600Q50148443-776F3C40-C4E1-4C09-82A2-5267AC751F1FQ55234596-F11E4D96-713E-4016-BF19-3394D69BB6DAQ55483598-D42A53FB-873C-4B0F-A19F-6AB8BD7046A8Q56888585-BCF95774-8E57-4965-91F2-395457D50502Q58556001-326CCC0F-76C2-4A8A-9246-7D332CB8451BQ58588749-8681AD13-6552-4C05-8765-88DB514CAB76Q58806208-168BA7E3-74B3-4062-BFA3-53B2E69F878E
P2860
Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Use of the National Health and ...... alence of urolithiasis in 2030
@ast
Use of the National Health and ...... alence of urolithiasis in 2030
@en
Use of the National Health and ...... alence of urolithiasis in 2030
@nl
type
label
Use of the National Health and ...... alence of urolithiasis in 2030
@ast
Use of the National Health and ...... alence of urolithiasis in 2030
@en
Use of the National Health and ...... alence of urolithiasis in 2030
@nl
prefLabel
Use of the National Health and ...... alence of urolithiasis in 2030
@ast
Use of the National Health and ...... alence of urolithiasis in 2030
@en
Use of the National Health and ...... alence of urolithiasis in 2030
@nl
P2093
P2860
P1433
P1476
Use of the National Health and ...... alence of urolithiasis in 2030
@en
P2093
Jodi A Antonelli
Margaret S Pearle
Naim M Maalouf
P2860
P304
P356
10.1016/J.EURURO.2014.06.036
P407
P50
P577
2014-07-09T00:00:00Z